Aderans Research Institute Inc (ARI), has achieved a significant milestone in Phase 2 of its cell-based hair regeneration study by treating the trial’s 100th hair loss subject. In the coming months, the study will double the number of participants. So far, the study has been conducted in eight US cities and will likely comprise up [...] [...more]
Aderans Research Institute (ARI) has purchased technology assets from Regenerative Medicine Assets Limited (formerly Intercytex Group plc), a UK based hair regeneration research company. “This acquisition is a major step forward for ARI,” said Vern Liebmann, Vice President of Operations. “Through this deal, we’ve been able to consolidate the majority of key patents and know-how [...] [...more]
